{"entity":{"id":"paper-bardach-hpv-vaccine-cea-venezuela-bmcph-2017","kind":"paper","name":"Cost-effectiveness of HPV vaccination for girls in Venezuela","aka":[],"tldr":"A Markov model of a cohort of 264,489 Venezuelan 11-year-old girls found the bivalent and quadrivalent HPV vaccines cost-saving compared with screening alone in all scenarios tested.","summary":"Published as \"Health economic evaluation of Human Papillomavirus vaccines in women from Venezuela by a lifetime Markov cohort model\". Authors from the Instituto de Efectividad Clínica y Sanitaria in Buenos Aires, Venezuelan public health researchers and two authors from GSK adapted a published model to Venezuela from the health payer's perspective, discounting costs and QALYs at 5%.","asOf":"2026-11-11","links":[{"label":"BMC Public Health 2017","url":"https://doi.org/10.1186/s12889-017-4064-7"},{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/28148228/"}],"tags":[],"related":[],"cancers":["cervical"],"sections":[],"technologies":["hpv-vaccine"],"targets":[],"drugs":[],"companies":[],"institutions":["venezuela-ministry-of-health"],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"journal":"BMC Public Health","year":2017,"doi":"10.1186/s12889-017-4064-7","pmid":"28148228","authors":"Bardach AE, Garay OU, Calderón M, et al.","paperType":"methods","findings":["Compared with screening only, the bivalent and quadrivalent vaccines were cost-saving in all eight scenarios, avoiding 2,310 and 2,143 deaths and 4,781 and 4,431 cervical cancers respectively.","They gained 4,486 and 4,395 discounted QALYs; neither vaccine was consistently more cost-effective than the other."],"whatItMeans":"Economic evidence for adding HPV vaccine to Venezuela's schedule; WHO's immunisation data still recorded the vaccine as not introduced nationally in 2025.","caveats":["GSK, which makes the bivalent vaccine, funded the study, and two authors were GSK employees.","Prices and exchange rates in Venezuela have changed greatly since the model was built."]},"route":"/key-papers/paper-bardach-hpv-vaccine-cea-venezuela-bmcph-2017/","neighbours":{"cancer":[{"id":"cervical","kind":"cancer","name":"Cervical cancer","route":"/cancers/cervical/"}],"technology":[{"id":"hpv-vaccine","kind":"technology","name":"HPV & HBV vaccination","route":"/technologies/hpv-vaccine/"}],"institution":[{"id":"venezuela-ministry-of-health","kind":"institution","name":"Ministerio del Poder Popular para la Salud (Venezuela)","route":"/institutions/venezuela-ministry-of-health/"}]}}